BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 31101760)

  • 1. Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy.
    Zhang Q; Green MD; Lang X; Lazarus J; Parsels JD; Wei S; Parsels LA; Shi J; Ramnath N; Wahl DR; Pasca di Magliano M; Frankel TL; Kryczek I; Lei YL; Lawrence TS; Zou W; Morgan MA
    Cancer Res; 2019 Aug; 79(15):3940-3951. PubMed ID: 31101760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STING (or SRC) Like an ICB: Priming the Immune Response in Pancreatic Cancer.
    Gutiontov SI; Weichselbaum RR
    Cancer Res; 2019 Aug; 79(15):3815-3817. PubMed ID: 31371279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer.
    Zhang Q; Jiang L; Wang W; Huber AK; Valvo VM; Jungles KM; Holcomb EA; Pearson AN; The S; Wang Z; Parsels LA; Parsels JD; Wahl DR; Rao A; Sahai V; Lawrence TS; Green MD; Morgan MA
    JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38376927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-9 blockade synergizes with ATM inhibition to induce potent anti-tumor immunity.
    Zheng S; Song J; Linghu D; Yang R; Liu B; Xue Z; Chen Q; Liu C; Zhong D; Hung MC; Sun L
    Int J Biol Sci; 2023; 19(3):981-993. PubMed ID: 36778120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
    Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation.
    Hu M; Zhou M; Bao X; Pan D; Jiao M; Liu X; Li F; Li CY
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33290271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia telangiectasia mutated kinase inhibition promotes irradiation-induced PD-L1 expression in tumour-associated macrophages through IFN-I/JAK signalling pathway.
    Gao Y; Li Y; Lin Z; Zeng Y; Huang Z; Han L; Zhong Y; Gong Y; Wu Q; Xie C
    Immunology; 2023 Feb; 168(2):346-361. PubMed ID: 36326481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death.
    Chiu LY; Sun Q; Zenke FT; Blaukat A; Vassilev LT
    Aging (Albany NY); 2023 Jan; 15(2):492-512. PubMed ID: 36656721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer.
    Liu C; Wang X; Qin W; Tu J; Li C; Zhao W; Ma L; Liu B; Qiu H; Yuan X
    Cancer Commun (Lond); 2023 Apr; 43(4):435-454. PubMed ID: 36855844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer.
    Sen T; Rodriguez BL; Chen L; Corte CMD; Morikawa N; Fujimoto J; Cristea S; Nguyen T; Diao L; Li L; Fan Y; Yang Y; Wang J; Glisson BS; Wistuba II; Sage J; Heymach JV; Gibbons DL; Byers LA
    Cancer Discov; 2019 May; 9(5):646-661. PubMed ID: 30777870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM Inhibition-Induced ISG15/IFI27/OASL Is Correlated with Immunotherapy Response and Inflamed Immunophenotype.
    Huang CH; Huang YC; Xu JK; Chen SY; Tseng LC; Huang JL; Lin CS
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic Cancer.
    Wang W; McMillan MT; Zhao X; Wang Z; Jiang L; Karnak D; Lima F; Parsels JD; Parsels LA; Lawrence TS; Frankel TL; Morgan MA; Green MD; Zhang Q
    Mol Cancer Res; 2022 Jul; 20(7):1137-1150. PubMed ID: 35348737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM inhibition augments type I interferon response and antitumor T-cell immunity when combined with radiation therapy in murine tumor models.
    Jin WJ; Zangl LM; Hyun M; Massoud E; Schroeder K; Alexandridis RA; Morris ZS
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37730275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal ATM siRNA delivery for enhancing triple-negaitive breast cancer immune checkpoint blockade therapy.
    Yu D; Wang H; Liu H; Xu R
    J Biomater Appl; 2023 May; 37(10):1835-1846. PubMed ID: 37016537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors.
    Wang L; Yang L; Wang C; Zhao W; Ju Z; Zhang W; Shen J; Peng Y; An C; Luu YT; Song S; Yap TA; Ajani JA; Mills GB; Shen X; Peng G
    J Clin Invest; 2020 Nov; 130(11):5951-5966. PubMed ID: 33016929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer.
    Jin MH; Nam AR; Park JE; Bang JH; Bang YJ; Oh DY
    Cancer Res Treat; 2020 Jan; 52(1):149-166. PubMed ID: 31291716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 and PD-L1 are negatively correlated with ATM and have impact on the prognosis of triple-negative breast cancer patients with low ATM expression.
    Song YM; Qian XL; Xia XQ; Li YQ; Sun YY; Jia YM; Wang J; Xue HQ; Gao GS; Wang XZ; Zhang XM; Guo XJ
    Breast Cancer Res Treat; 2022 Nov; 196(1):45-56. PubMed ID: 36056297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC.
    Taniguchi H; Caeser R; Chavan SS; Zhan YA; Chow A; Manoj P; Uddin F; Kitai H; Qu R; Hayatt O; Shah NS; Quintanal Villalonga Á; Allaj V; Nguyen EM; Chan J; Michel AO; Mukae H; de Stanchina E; Rudin CM; Sen T
    Cell Rep; 2022 May; 39(7):110814. PubMed ID: 35584676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way.
    Yu X; Long Y; Chen B; Tong Y; Shan M; Jia X; Hu C; Liu M; Zhou J; Tang F; Lu H; Chen R; Xu P; Huang W; Ren J; Wan Y; Sun J; Li J; Jin G; Gong L
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36253000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.